EHR523: Complex Clinical Reasoning and Decision-Making in Exercise Oncology

Foundations of Clinical Reasoning in Exercise Oncology

• Complexity as the Baseline in Practice:

  • People affected by cancer typically present with multiple, interconnected, and competing clinical concerns, including direct oncological effects, acute treatment toxicities, persistent adverse effects, and pre-existing comorbidities.
  • Clinical decision-making in oncology is rarely straightforward or linear; decisions routinely require balancing trade-offs between competing physiological, psychological, and medical priorities.
  • The primary clinical challenge extends beyond merely cataloguing or identifying pathology; clinicians must synthesize multifaceted data to determine the most appropriate, individualized, and timely course of action.

• Requirements of a Structured Approach to Decision-Making:

  • Clinicians must manage cognitive complexity by evaluating multiple competing variables simultaneously rather than in isolation.
  • Decisions frequently must be formulated in scenarios characterized by ambiguity, where no single predetermined "correct" answer or rigid clinical pathway exists.
  • Clinicians are required to balance short-term acute stability with long-term rehabilitative and physiological objectives.
  • Exercise interventions must possess sufficient structural agility to adapt continuously to rapidly evolving clinical circumstances, medical regimens, and disease trajectories.
  • The overarching objective is the delivery of care that is concurrently safe, clinically efficacious, and fundamentally centered around the patient's lived experience.
  • A structured framework comprising six core principles provides the foundation for navigating complex clinical presentations in exercise oncology: Treat the Person, Not the Diagnosis; Prioritise Before Prescribing; Focus on Meaningful Outcomes; Manage Clinical Risk; Accept and Manage Uncertainty; and Reassess and Adapt.

Principle 1: Treat the Person, Not the Diagnosis

• Contextualizing the Oncological Diagnosis:

  • A primary cancer diagnosis establishes clinical context, pathophysiology, and expected risk profiles, but it does not dictate a singular exercise prescription or management plan.
  • Patients presenting with identical primary tumor types, stages, histological grades, or biomedical treatments often require profoundly divergent exercise management strategies based on systemic health, functional reserves, and personal circumstances.
  • The central clinical reasoning question to guide assessment is: What do I need to understand about this person beyond their diagnosis?

• Comprehensive Assessment of the Individual:

  • Individual Goals and Priorities: Identifying what the individual specifically hopes to achieve through exercise rehabilitation.
  • Meaningful Activities: Pinpointing the daily tasks, familial roles, hobbies, and occupational duties that give purpose to the individual's life.
  • Limitations and Barriers: Recognizing physical impairments, fatigue thresholds, transportation challenges, treatment schedules, and psychological distress that impede adherence.
  • Psychosocial and Cultural Circumstances: Factoring in family support structures, financial resources, health literacy, and cultural values surrounding illness, physical exertion, and rest.
  • Patient-Defined Success: Establishing criteria for successful intervention based on the patient's personal value system rather than relying exclusively on standardized normative fitness data.

• Multidisciplinary Collaboration and Allied Health Referral Networks:

  • Complex oncology presentations routinely surpass the professional scope of practice of a single discipline, requiring proactive interprofessional communication and cross-referral.
  • Cachexia and Unintentional Weight Loss: Requires collaborative referral to an Accredited Practising Dietitian for specialized nutritional support, energy balance optimization, and metabolic management.
  • Mobility Limitations and Neurological Impairments: Requires input from a Physiotherapist for specialized musculoskeletal rehabilitation, gait re-education, neuromuscular retraining, and mobility aid prescription.
  • Fear of Movement (Kinesiophobia), Anxiety, and Severe Distress: Requires intervention from a Clinical Psychologist to provide cognitive-behavioral strategies, trauma-informed care, and psychological coping mechanisms.
  • Social, Practical, or Financial Challenges: Requires engagement with an Oncology Social Worker to navigate healthcare access, transport assistance, workplace accommodations, and socioeconomic support structures.

Principle 2: Prioritise Before Prescribing and the Five Clinical Priorities

• Foundations of Systematic Prioritization:

  • Clinicians cannot remediate all physiological, functional, and psychological deficits simultaneously without risking patient overburden, non-adherence, or adverse events.
  • Prioritization focuses therapeutic resources on impairments and risks that exert the most profound influence on immediate patient safety, autonomy, and participation.
  • Prioritizing care is not an act of discarding issues as unimportant; rather, it is determining precisely what demands clinical focus in the present moment.
  • The central clinical reasoning question is: What is the most important issue to address today?

• Priority 1: Address Immediate Safety Concerns:

  • Guiding Query: Are there any concerns that require immediate attention so exercise can proceed safely?
  • Focuses on identifying pathology, toxicities, or clinical changes that present acute medical risks during physical activity.
  • Immediate safety factors must be medically investigated, stabilized, or mitigated before any progression or initiation of an exercise prescription.
  • Clinical Examples: New or acute neurological changes (e.g., motor deficits, sensory ataxia, suspected spinal cord compression); severe acute mobility limitations; sudden escalation of severe symptoms (e.g., bone pain, acute dyspnea, resting chest tightness); laboratory or systemic indicators requiring immediate medical review or oncologist clearance.

• Priority 2: Preserve Function and Independence:

  • Guiding Query: What functional abilities are most important to preserve or improve?
  • Maintaining physical autonomy represents the primary objective for many individuals navigating cancer treatment.
  • Preserving functional ability directly underpins the patient's capacity to safely execute daily tasks, maintain home independence, and sustain long-term physical activity participation.
  • Functional rehabilitation is vital following major surgical resection or during debilitating systemic therapies.
  • Clinical Examples: Basic and instrumental Activities of Daily Living (ADLs); sit-to-stand and bed transfers; gait stability, walking endurance, and distance tolerance; safe stair negotiation.

• Priority 3: Manage Symptoms and Treatment Effects:

  • Guiding Query: Which symptoms most affect the patient's day-to-day life?
  • Acute, subacute, and chronic treatment toxicities directly degrade overall quality of life and limit functional capacity.
  • Targeted exercise prescription can alleviate symptom severity, thereby enhancing participation in both exercise therapy and routine activities.
  • Symptom priorities are dynamic, fluctuating between chemotherapy cycles, radiation blocks, and immunotherapy infusions.
  • Clinical Examples: Cancer-related fatigue (CRF); chemotherapy-induced peripheral neuropathy (CIPN); acute, post-surgical, or musculoskeletal pain.

• Priority 4: Build Physical Capacity:

  • Guiding Query: How can exercise support the patient's current and future physical capacity?
  • Physiological adaptations in muscular and cardiorespiratory systems reduce treatment-induced functional decline, blunt toxicities, and accelerate recovery post-treatment.
  • Capacity building must be programmed progressively to match the patient's current tolerance, medical status, and personal preferences.
  • Enhanced physical capacity directly translates to sustained participation in occupational, recreational, and familial activities.
  • Clinical Examples: Cardiorespiratory and aerobic fitness; skeletal muscle mass and muscular strength; static and dynamic balance; sustained daily physical activity volume.

• Priority 5: Pursue Long-Term Health and Lifestyle Goals:

  • Guiding Query: What longer-term outcomes are important to this patient?
  • Encompasses health objectives extending beyond immediate tumor eradication and acute toxicity management.
  • These goals inform ongoing survivorship planning, mitigating secondary cancer risks, and reducing late-emerging treatment effects.
  • Clinical Examples: Long-term weight management and body composition optimization; cardiometabolic disease risk mitigation; phased return to work and vocational duties; independent, long-term adherence to recreational physical activity.

• Operationalizing Prioritization in Practice:

  • When multiple co-existing issues are identified, attention must be weighted toward the most urgent and clinically impactful factors.
  • Priorities are fluid and must be re-ranked as systemic treatment plans change, toxicities wax and wane, or functional status shifts.

Principle 3: Focus on Meaningful Outcomes Across the Continuum

• Defining Success Beyond Standard Metrics:

  • Outcomes must align with the individual's lived values, self-worth, and existential priorities.
  • Success in exercise oncology cannot be measured solely by physiological adaptations, volume benchmarks, or standard strength and fitness indices.
  • The central clinical reasoning question is: What does success look like for this individual?

• Outcome Variation Across the Cancer Continuum (Treatment Phase and PACC Framework):

  • During Active Treatment: Success centers on attenuating physiological decline, preserving functional capacity, managing treatment-limiting side effects, and supporting high adherence to prescribed oncological therapy.
  • Following Treatment (Survivorship / Rehabilitation): Success involves regaining lost physiological capacity, rebuilding skeletal muscle and aerobic fitness, overcoming persistent toxicities, and facilitating full reintegration into community, recreational, and occupational roles.
  • Advanced / Metastatic Disease: Success shifts toward preserving functional autonomy, slowing physical and functional decline, managing pain and physical discomfort, and optimizing energy utilization for high-priority life activities.
  • Palliative and End-of-Life Care: Success is defined by maximizing bodily comfort, preserving personal dignity and autonomy, supporting continued physical contact with loved ones, and enhancing quality of life (QOL).

• Individualized, Patient-Centred Outcome Metrics:

  • Goals must bridge physiological adaptations with practical life activities across six core domains: Independence, Participation, Symptom Management, Confidence, Physical Capacity, and Quality of Life.
  • Exemplar Patient-Centred Functional Goals: Walking independently to local shops without stopping to rest; climbing household stairs daily without physical assistance; retaining sufficient physical strength and stamina to care for children or grandchildren; maintaining functional self-sufficiency to live independently at home; attending regular weekly social, recreational, or community events.

Principle 4: Clinical Risk Management and Decision Trade-Offs

• The Continuum of Benefit and Risk:

  • Clinical decision-making in complex oncology requires continuous evaluation of potential therapeutic gains relative to clinical risks.
  • No therapeutic exercise intervention is completely devoid of risk; however, clinical inertia and excessive exercise avoidance introduce substantial biological and functional hazards, including accelerated sarcopenia, deconditioning, and increased vulnerability to treatment toxicities.
  • The objective of clinical risk management is not the complete eradication of risk through under-prescription, but rather the safe maximization of meaningful benefit within an acceptable risk tolerance.
  • The central clinical reasoning question is: What approach provides the greatest overall benefit while maintaining an acceptable level of risk?

• Navigating Key Clinical Trade-Offs:

  • Exercise Progression versus Symptom Burden: Determining when to advance loading parameters to stimulate physiological adaptation without provoking an acute exacerbation of debilitating symptoms (e.g., post-exertional fatigue, nausea, peripheral neuropathy flare-ups).
  • Independence versus Safety: Deciding when to encourage independent, unassisted home- or community-based physical activity versus mandating direct, supervised exercise to protect against falls, fractures, or physiological destabilization.
  • Mechanical Loading versus Skeletal Risk: Formulating osteogenic or muscle-strengthening prescriptions (e.g., targeted resistance training, impact loading) while safeguarding skeletal sites vulnerable to bone metastases, pathological fractures, or severe osteoporosis.
  • Developing Capacity versus Preserving Energy: Balancing the energetic cost required to stimulate long-term cardiorespiratory and muscular hypertrophy against the patient's immediate energy conservation needs for essential daily activities and treatment tolerance.

• A Systematic Process for Managing Clinical Risk:

  • Identify Potential Risks: Systematically screen for disease-specific, treatment-related, and patient-specific vulnerabilities (e.g., cytopenias, cardiac toxicities, bone lesions, fall history).
  • Consider Potential Benefits: Clarify the specific physical, functional, and psychological benefits sought from the proposed exercise stimulus.
  • Evaluate Competing Priorities: Weigh the clinical trade-offs to determine which priority takes precedence at the current juncture.
  • Implement Appropriate Safeguards: Apply targeted modifications, including non-impact exercise modalities, seated variations, biomechanical offloading, range-of-motion constraints, or environmental modifications.
  • Monitor and Adapt over Time: Continually evaluate real-time physiological and symptom responses during and following exercise, modifying parameters dynamically.

Principle 5: Navigating Clinical Uncertainty

• Normalizing Uncertainty in Oncology Practice:

  • Oncology clinicians regularly operate with ambiguous, missing, or rapidly shifting diagnostic and prognostic data.
  • Clinical practice guidelines and population-level evidence provide broad guidance but do not offer definitive answers for complex multi-morbidity presentations.
  • Uncertainty is an inherent reality of specialized clinical practice rather than a personal clinical failing.
  • The central clinical reasoning question is: What is the best decision based on the information currently available?

• Common Sources of Uncertainty and Applied Clinical Strategies:

  • Incomplete Information: When medical history or recent clinical records are fragmented, the clinician must proactively assemble the best available collateral data from the patient, caregivers, and medical teams.
  • Limited Referral Details: When medical clearance or referral notes lack granular clinical parameters (e.g., specific metastasis locations, recent surgical precautions), the clinician must directly contact the referring specialist or oncology nurse to seek clarification.
  • Unclear Clinical Findings: When signs or symptoms cannot be definitively categorized (e.g., non-specific musculoskeletal aching versus early metastatic bone pain), the clinician must exercise informed caution, avoid high-risk loading at the symptomatic region, and initiate diagnostic escalation.
  • Evolving Disease Status: When tumor progression, remission, or treatment protocols are in flux, the clinician must establish frequent, formal reassessment intervals to closely track systemic status.
  • Evidence Gaps: When literature is lacking for a specific rare cancer or unique multi-morbid presentation, the clinician must synthesize core physiological principles, contextual understanding, and evidence-informed judgement to design a conservative, individualized prescription.

Principle 6: Continuous Reassessment and Dynamic Adaptation

• The Dynamic Nature of the Cancer Trajectory:

  • A patient's physiological capacity, symptom profiles, toxicities, treatment protocols, and personal values change dynamically over the course of the cancer journey.
  • Exercise oncology prescriptions must function as flexible, iterative interventions rather than rigid, static regimens.
  • The central clinical reasoning question is: Has anything changed that requires updating or revising the plan?

• Core Evaluative Queries During Clinical Reassessment:

  • What's working? Evaluating which aspects of the current prescription are effectively driving functional improvements, alleviating symptoms, and sustaining patient adherence and confidence.
  • What needs modification? Identifying exercises, loading parameters, or delivery modes that are generating excessive fatigue, exacerbating musculoskeletal pain, precipitating neuropathy distress, or producing poor adherence.
  • Whether priorities have changed? Re-evaluating whether emerging clinical events (e.g., disease recurrence, treatment alterations, surgery) or altered personal goals necessitate a fundamental restructuring of the care hierarchy.

Synthesis of Principles, Common Decision Pitfalls, and Clinician Competencies

• Summary Matrix: The Six Principles in Practice:

  • Start with the Person: Understand the person beyond the diagnosis.
  • Prioritise Before Prescribing: Focus on what matters most right now.
  • Focus on Meaningful Outcomes: Align outcomes with patient priorities.
  • Manage Clinical Risk: Balance risk while pursuing meaningful benefit.
  • Accept and Manage Uncertainty: Make informed decisions with available information.
  • Reassess and Adapt: Monitor, reflect, and adjust over time.

• Common Pitfalls in Oncology Clinical Decision-Making:

  • Over-emphasising Risk and Under-prescribing Exercise: Allowing clinical apprehension to result in trivial exercise dosages that fail to meet minimum physiological thresholds required to stimulate adaptation, thereby depriving the patient of therapeutic benefit.
  • Attempting to Address Too Many Problems at Once: Creating overly complex, burdensome programs that overwhelm the patient's physiological reserve and psychological bandwidth, resulting in poor adherence or exhaustion.
  • Applying Evidence Without Considering the Individual: Blindly superimposing standardized exercise trial protocols or population guidelines onto a unique individual without adjusting for personal values, comorbidities, and lived barriers.
  • Failing to Adapt as Circumstances Change: Persisting with an established exercise program despite significant alterations in the patient's medical status, disease progression, treatment schedule, or symptom profile.

• Characteristics of Effective Exercise Oncology Clinicians:

  • Critical Thinking: They utilize sophisticated clinical reasoning rather than defaulting to generic formulas or rigid, unreflective algorithms.
  • Interprofessional Communication: They engage in open, precise communication with patients, families, and multidisciplinary oncology and allied health teams.
  • Evidence-Informed Practice: They apply current scientific literature rigorously while openly recognizing its inherent boundaries, translational challenges, and evidence gaps.
  • Adaptability: They remain flexible, composed, and responsive when confronted with clinical uncertainty, evolving prognoses, and sudden patient status fluctuations.
  • Reflective Practice: They critically evaluate their own clinical judgments, examine past interventions, and continuously refine their professional expertise.
  • Patient-Centred Focus: They ground all clinical decision-making within the patient's individual autonomy, dignity, and evolving goals across the entire cancer continuum.